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Hepatitis C virus (HCV) core protein has multifunctional activities. We have previously reported that the core protein of HCV
immortalizes primary human hepatocytes, which may relate to multistage hepatocarcinogenic events. These immortalized human hepatocytes
(IHH) served as a model to study the mechanism of HCV core protein-mediated cell growth regulation. Inhibition of core protein expression
in earlier stages after hepatocyte immortalization leads to the induction of apoptosis. Here, we have observed that introduction of antisense
core (AS-Core) sequences for inhibition of core protein expression enhanced the expression of E2F1 and p53 levels in early passage IHH.
Inhibition of core protein expression also altered the expression level of Bcl-2 family proteins, displaying an increase of the proapoptotic Bax
and a decrease in the level of the anti-apoptotic Bcl-xL proteins. These alterations, however, did not result in the release of cytochrome c from
the mitochondria. Apaf-1 is frequently deregulated under various pathologic conditions, and examination of AS-Core-expressing apoptotic
cells indicated a significant increase in the level of Apaf-1, which coincided with caspase-9 activation. Knockdown of Apaf-1 or the
transcriptional regulatory proteins, E2F1 or p53, by small interfering RNA (siRNA) duplexes inhibited the activation of caspase-9 and
enhanced cell viability in AS-Core-expressing cells. These findings may contribute to the understanding of the pathophysiology of HCV core
protein-mediated hepatocyte growth regulation and disease progression.
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HCV is a major public health problem, with more than
170 million people chronically infected worldwide. The
most important feature of HCV infection is the development
of chronic hepatitis in ¨80% of the infected individuals and
the potential for disease progression to cirrhosis and
hepatocellular carcinoma (Jeffers, 2000; Saito et al.,
1990). Studies on HCV are challenging due to the lack of0042-6822/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
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E-mail address: rayr@slu.edu (R. Ray).a suitable cell culture system and the absence of a small
animal model.
Overproduction and release of core protein have been
observed in the blood stream of HCV infected hosts
(Maillard et al., 2001). HCV core protein immortalizes
primary human hepatocytes, the natural host for virus
replication (Ray et al., 2000). These immortalized human
hepatocytes (IHHs) exhibit activation of telomerase function
and continuous growth in cell culture. Hepatocarcinogenesis
involves alterations in the concerted action of proto-
oncogenes, growth factors, and tumor suppressor genes.
HCV core protein regulates p53, p21, c-myc promoter
activities, and cyclin E (Cho et al., 2001; Kwun and Jang,
2003; Ray et al., 1997, 1998; Siavoshian et al., 2004).05) 198 – 207
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which correlates with the activation of JNK and MAPKK
(Marusawa et al., 1999; Shrivastava et al., 1998). Premature
senescence involving p53 is activated in response to
constitutive MEK/MAPK mitogenic signaling (Lin et al.,
1998). We observed a weak level of core protein expression
in IHH, which is sufficient for the maintenance of cell
growth, and below which early passage immortalized
hepatocytes fail to survive (Basu et al., 2002).
A fundamental aspect of p53 is its ability to participate in
cell-cycle checkpoint and apoptosis functions that regulate
homeostatic tissue renewal. Exogenous p53 expression can
suppress the transformed phenotype of many cell types by
inducing growth arrest and apoptosis (Soddu and Sacchi,
1998). The modulation of p53 by adenovirus E4 or E6
proteins, HTLV-1 Tax protein, SV40 T antigen, and the E6/
E7 gene products of HPV-16 and 18 plays a role in cell
growth regulation (Herzig et al., 1999; Nevels et al., 1999a,
1999b; Steegenga et al., 1999; Uittenbogaard et al., 1995).
A constant expression of SV40 T-antigen is necessary for
the maintenance of immortalized human fibroblasts (Radna
et al., 1989), and antisense E7 RNA of HPV-18 causes death
of an oral cancer cell line–1483–after a lag period (Steele et
al., 1992). Results from our previous studies have suggested
that HCV core protein can modulate p53 gene expression,
which may contribute to the immortalization of primary
human hepatocytes and growth (Basu et al., 2002; Ray et
al., 2000).
Activation of p53 may occur due to an overexpression
of E2F1. The p14ARF protein, identified as an E2F target
gene, stabilizes p53 and may provide a link between E2F1
and an elevation in p53 levels (Bates et al., 1998). E2F1 is
a member of a family of transcription factors and acts to
control the G1/S transition in embryotic cells (Harbour
and Dean, 2000). In response to mitogenic stimuli, E2F1
is induced in quiescent cells and promotes both cell cycle
progression and apoptosis (Nevins, 1998). Apaf-1 is
transcriptionally activated by p53 and E2F1 (Moroni et
al., 2001), and is a mediator of apoptosis. An increase in
Apaf-1 levels has been associated with the direct
activation of caspase-9 without mitochondrial damage
and leads to the initiation of a caspase cascade (Furukawa
et al., 2002).
Immortalization of primary human hepatocytes by HCV
core protein may be a result of a regulatory role on cellular
gene(s) leading to an alteration in hepatocyte turnover,
although the mechanism of core protein-mediated cellular
gene regulation is not well understood (Ray and Ray,
2001). HCV core protein has multifunctional activities
similar to that seen in a number of other viral proteins with
oncogenic potential. The immortalization of a primary
human epithelial cell occurs through a multistep process,
and many of these steps are not fully understood.
Interestingly, inhibition of core protein expression did not
alter the growth property of late passage IHH (passage 50)
when cells were exhibiting anchorage-independent growth,in contrast to early passage IHH (passage 15). This
suggested that HCV core protein is required for the
maintenance of this phenotypic change in the early stages
after hepatocyte immortalization (Basu et al., 2002; Ray et
al., 2000).
In the present study, we have utilized IHH as a model to
study the role of HCV core protein-mediated cellular
functions, particularly with regard to the mechanism of
immortalization. We have investigated the signaling path-
way by which IHHs undergo apoptosis upon inhibition of
HCV core protein expression. Our results demonstrate a
novel mechanism of apoptosis in which hepatocyte death
correlates with an increase in Apaf-1. The subsequent
activation of caspase-9, leading to the initiation of the
intrinsic cell death pathway, occurs in the absence of
cytochrome c translocation to the cytosol.Results
Differentially expressed E2F1 and p53 genes in IHH
Atlas cDNA expression membrane (Human Oncogene/
Tumor Suppressor Array) was used to identify genes
induced in response HCV core protein expression in IHH.
Total RNAs isolated from HCV core-transfected IHH and
from paired donor hepatocytes were used to generate 32P-
labeled cDNA probes for the hybridization of Atlas cDNA
expression membrane. Modulated genes were selected as
described under Materials and methods and a detailed
description of the gene expression analyses will be reported
separately. Among the genes of interest from our previous
studies (Basu et al., 2002; Ray et al., 2000), both E2F1 and
p53 were reduced early after immortalization of the primary
human hepatocytes by HCV core (passage number15) as
compared to primary hepatocytes from matching donors.
Each passage number represented cells from ¨4 days of
culture. Real-time PCR verified an ¨35% decrease in E2F1
and ¨50% decrease in p53.
p53 is known to play a key role in growth arrest, DNA
repair, and apoptosis after cell stress, primarily through its
ability to regulate the transcription of downstream cellular
target genes. AS-Core gene expression in early passage
IHH (passage 15) induces an apoptotic response (Basu et
al., 2002). Inhibition of core gene expression led to an ¨5-
fold increase in protein expression of p53 as compared to
vector control in early passage IHH which preceded
apoptosis (Fig. 1, panel A). Inhibition of core gene
expression also increased E2F1 protein expression by
¨2-fold in early passage IHH (Fig. 1, panel B). These
results corroborated the data derived from Atlas cDNA
expression and real-time PCR, suggesting that the regu-
lation of p53 and E2F1 genes occurred at the transcrip-
tional level.
To examine whether p53 or E2F1 is responsible for AS-
Core-mediated apoptosis, we knocked down p53 or E2F1
Fig. 2. Inhibition of core protein expression in IHH modulates Bax and Bcl-
xL expression levels. (Panel A) Analysis of Bcl-2 family mRNA expression
level in response to antisense core induction by RNAse protection assay.
The mRNA expression levels of Bcl-xL, Bax, Bcl-2, and L32 (internal
control) were determined in IHH-expressing antisense core gene sequences
(AS-Core) and in empty vector control cells. (Panel B) Effect of inhibition
of core gene expression on Bax, Bcl-xL, and Bcl-2 proteins in AS-Core or
empty vector-introduced IHH. Cell lysates were subjected to Western blot
analysis using specific antibodies. The level of cellular actin was used as an
internal control for comparison. Molecular weights of the identified protein
bands were validated from the positions of prestained molecular weight
markers (Bio-Rad).
Fig. 1. Correlation of IHH apoptosis with p53 and E2F1. ZnCl2-induced
AS-Core or empty vector control cells were electroporated with 100 nM
sip53 or siE2F1 (Santa Cruz). Cells were subjected to Western blot analysis
for the detection of p53 (panel A) and E2F1 (panel B) levels. siRNA-
transfected hepatocytes were also analyzed for apoptotic cell death by
ELISA (Roche) following induction with ZnCl2 (panel C).
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examined their relative protein expression levels, and cell
death in response to AS-Core induction. AS-Core cells were
incubated in the presence of 50 AM ZnCl2 for 5 days,
followed by electroporation with the indicated siRNAs.
Cells were added on a collagen-coated plate and incubated
in medium supplemented with 50 AM ZnCl2 until the AS-
Core control cells exhibited a significant level (>80%) of
death. The introduction of siRNA to p53 (sip53) resulted in
¨20-fold decrease in the level of p53 expression in AS-
Core-induced cells as compared to AS-Core control cell
lysates (Fig. 1, panel A). In a similar manner, siRNA to
E2F1 (siE2F1) effectively reduced the level of E2F1 protein
in AS-Core-induced cells by 4- to 5-fold (Fig. 1, panel B).
Apoptosis was evaluated by cell death ELISA (Fig. 1, panel
C), and cell death induced by AS-Core was significantly
inhibited with either sip53 or siE2F1 when compared with
unrelated siRNA-transfected cells. These results suggest that
the regulation of p53 and E2F1 by HCV core protein
expression contributes to the suppression of apoptotic
response in hepatocytes.Regulation of Bcl-2 family proteins by HCV core
p53 induces the expression of Bax, a proapoptotic
member of the Bcl-2 family of proteins (Miyashita et al.,
1994; Selvakumaran et al., 1994), while also acting to
down-regulate the anti-apoptotic Bcl-2 protein (Haldar et
al., 1994). RNAse protection assay for certain members of
the Bcl-2 protein family indicated an ¨3-fold increase in
the expression of Bax mRNA level following AS-Core
induction, while the levels of the anti-apoptotic Bcl-2 and
Bcl-xL mRNAs remained relatively unchanged (Fig. 2,
panel A). We further investigated the potential for HCV
core protein to modulate members of the Bcl-2 family (Bcl-
2, Bcl-xL, Bax) at the protein level by Western blot
analysis. Protein loaded in each lane was normalized with
the level of cellular actin. Our results suggested an ¨4-fold
increase in the level of Bax expression after AS-Core gene
induction as compared to vector control cells. In contrast,
the level of Bcl-xL protein under these conditions was
K. Meyer et al. / Virology 336 (2005) 198–207 201found to decrease by a similar margin, while Bcl-2 levels
remained unchanged (Fig. 2, panel B). The difference
between the RNA and protein levels of Bcl-xL could be due
to a post-transcriptional alteration, resulting in increased
stability for Bcl-xL. These results indicated that the ex-
pression of HCV core protein in immortalized hepatocytes
might act to suppress an apoptotic response via a modu-
lation of the Bcl-2 family of proteins. In this case, limiting
the transcription level of proapoptotic Bax, while en-
couraging a cellular environment that post-transcriptionally
enhances Bcl-xL protein levels.
Apoptosis of immortalized hepatocytes is independent of
cytochrome c pathway and relies on the inhibition of core
protein expression
The p53 apoptotic target genes can be divided into two
groups, the first group encodes proteins that act through
receptor-mediated signaling, while those of the second
group regulate apoptotic effector proteins and include
members of the Bcl-2 family of proteins (Vermeulen et
al., 2003). Bcl-2 may act to directly promote cell survival
by interfering with the activation of the intrinsic apoptotic
pathway (Yang et al., 1997). The positive and negative
regulation of an apoptotic response is often determined by
the relative ratios and dimerization status of Bcl-2 and Bax
(Cory and Adams, 2002). Homodimers of Bcl-2 block
apoptosis, whereas Bax homodimers elicit the opposite
effect, and Bcl-2–Bax heterodimers are inactive. In a
similar fashion, the Bcl-xL protein is able to interact with
the pro-apoptotic Bax and Bak proteins, with the potential
to affect cell viability. As p53 activates the transcription of
Bax, it alters the balance of Bcl-2 and Bax, leading to the
potential release of cytochrome c from the mitochondria,
activating a caspase-9-associated cascade that ultimately
leads to apoptosis (Sionov and Haupt, 1999). During
apoptosis induced by diverse stimuli, cytochrome c is
released from the mitochondria into the cytosol (Bossy-
Wetzel et al., 1998; Kharbanda et al., 1997; Kluck et al.,
1997; Yang et al., 1997). Upon translocation, cytochrome c
is able to initiate the final steps of the intrinsic apoptotic
pathway, triggering the oligomerization of Apaf-1 with
procaspase-9 in a multimeric complex. This oligomeriza-
tion forms the complex by which caspase-9 is activated,
subsequently leading to initiation of the final steps of the
caspase cascade. Bcl-xL may also further hinder the
intrinsic apoptotic pathway by directly binding to cyto-
chrome c, thereby sequestering it in the outer mitochondrial
membrane (Kharbanda et al., 1997).
We examined the intracellular distribution of cytochrome
c using confocal microscopy (Fig. 3, panels A–C).
Immortalized hepatocytes expressing an antisense core gene
under the control of an inducible promoter or vector control
cells were treated with mitotracker dye for 30 min and
immunostained with a mouse monoclonal antibody to
cytochrome c for confocal microscopy as describedpreviously (Ghosh et al., 2002). Cytochrome c was stained
in a punctate pattern indicative of intramitochondrial
localization in IHH. The pattern of cytochrome c distribu-
tion remained similar within AS-Core gene-expressing cells
after induction of cell death. These results indicated that
cytochrome c translocation is not a prerequisite for
apoptosis following the inhibition of HCV core protein
expression in the IHH. On the other hand, transduction of
IHH by a replication-deficient adenovirus construct
expressing MBP-1, an unrelated protein, also did not
display a cytosolic accumulation of cytochrome c (Fig. 3,
panels D–F). However, when MBP-1 was transduced in
HeLa or MCF-7 cells, cytochrome c release from
mitochondria to cytosol was observed (Ghosh et al.,
2002). Subcellular fractionation of IHH was also performed
to verify the localization of cytochrome c after AS-Core
gene or MBP-1 expression (Fig. 3, panel G). Cytochrome c
in apoptotic cells was observed predominantly within the
membrane fraction, instead of the soluble cytosolic
fraction, in a manner similar to vector control cells,
indicating a retention of the protein within the mitochon-
dria. These observations suggest that the cytochrome c-
dependent intrinsic pathway is inhibited in IHH and the
generation of an AS-Core-related apoptotic response must
act to circumnavigate this restriction.
Apaf-1 expression level is regulated by AS-Core induction
We examined the status of Apaf-1, a central protein in the
apoptosome, which has been observed to regulate apoptosis
in the absence of cytochrome c release. Cell lysates were
examined prior to and after the onset of apoptosis derived
from AS-Core gene expression. Prior to the onset of
apoptosis, there was only a slight indication of Apaf-1
protein expression, and induction of vector control trans-
fected cells exhibited no increase in the level of Apaf-1.
However, we observed an ¨3-fold increase in Apaf-1 levels
in AS-Core gene-expressing cells that were undergoing
apoptosis, as well as an ¨10-fold increase in the appearance
of an ¨84-kDa band associated with a post-apoptotic
proteolytic cleavage of Apaf-1 (Fig. 4).
Although inhibition of HCV core protein expression
clearly leads to the upregulation of Apaf-1, it is still
unclear whether this induction is responsible for the
initiation of apoptosis. To address this question, Apaf-1
expression was inhibited by a specific siRNA duplex, and
its effect on cell death in response to AS-Core gene
expression was examined. Cell death was evaluated by
ELISA against uninduced AS-Core cells as a background
and the results are presented as % apoptosis. Cells treated
with siApaf-1 exhibited a suppression of Apaf-1 expres-
sion to a level similar to that found in the vector control
cell line (Fig. 5, panel A), and ¨2.5-fold lower apoptosis
than AS-Core-induced cells (Fig. 5, panel B). A significant
decrease in observed cell death, coinciding with a
reduction in this protein, suggests that Apaf-1 induction
Fig. 4. Inhibition of core gene expression activates Apaf-1 in the IHH. AS-
Core or empty vector control cell lysates were subjected to Western blot
analysis using an Apaf-1-specific antibody. The level of cellular actin was
used as an internal control for comparison. Molecular weights of the
identified protein bands were validated from the positions of prestained
molecular weight markers (Bio-Rad).
Fig. 3. AS-Core gene expression in the IHH does not induce release of cytochrome c from the mitochondria. Cells exhibiting AS-Core gene (panels A–C)
expression or MBP-1 as a unrelated control (panels D–F) were treated with mitotracker dye for 30 min. Cells were subsequently fixed and immunostained with
a monoclonal antibody to cytochrome c and a secondary antibody conjugated to Alexa-568 fluorochrome (panel B) for confocal microscopy. Cells exhibited a
diffuse immunostaining of cytochrome c (panels A and D) in the mitochondria. Fluorescence images of the mitotracker dye (panels B and E) and cytochrome c
were superimposed digitally (panels C and F) for fine comparison to demonstrate integrity of the mitochondria. Localization of cytochrome c in subcellular
fractions is also shown from AS-Core, empty vector control, and MBP-1-treated cells (panel G) by Western blot analysis. The results suggested membrane
association of cytochrome c using a specific rabbit polyclonal antibody.
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of p53 or E2F1 was examined to further explore the
regulation of Apaf-1 in AS-Core-induced cells. The
introduction of sip53 into AS-Core cells led to an ¨2.8-
fold reduction in the level of Apaf-1 expression in ZnCl2-
induced AS-Core cells, while the induction of siE2F1
sequences led to an ¨4.4-fold reduction in the level of
Apaf-1 (Fig. 5, panel C). These results further suggested
that Apaf-1, p53, and E2F1 are associated with apoptosis
in IHH.
Antisense core gene expression activates procaspase-9
preceding activation of caspase-7 in immortalized
hepatocytes
We determined the activation level of initiator procaspase-
9, an upstream activator of procaspase-3 and-7, in control
and AS-Core-expressing IHH lysates by Western blot
analysis. Upon activation, the proenzyme is cleaved to
the active polypeptides of caspase-9 (¨35 kDa and ¨10
Fig. 5. Up-regulation of Apaf-1 correlates with antisense core-induced apoptosis. (Panel A) AS-Core or empty vector control cells were induced with ZnCl2 for
inhibition of HCV core protein expression after introduction of 100 nM siRNA to Apaf-1. Cell lysates were subjected to Western blot analysis for detection of
Apaf-1 expression level. The level of cellular actin was used as an internal control for comparison. (Panel B) siRNA (100 nM) directed to Apaf-1 was
transfected into hepatocytes, induced with ZnCl2, and analyzed for apoptotic cell death by ELISA (Roche). The % apoptosis was calculated after subtraction of
the background value of uninduced AS-Core cells. (Panel C) Inhibition of p53 or E2F1 by specific siRNA decreased Apaf-1 level in AS-Core-expressing cells.
The level of cellular actin was used as an internal control for comparison. Molecular weights of the identified protein bands were validated from the positions of
prestained molecular weight markers (Bio-Rad).
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both the procaspase-9 and cleaved ¨35-kDa form. IHH
induced to express AS-Core sequences exhibited a
significantly increased level of cleaved ¨35-kDa polypep-
tide of caspase-9 as compared to vector control (Fig. 6).
The presence of sip53 or siE2F1, and siApaf-1, inhibited
the activation of procaspase-9. The blot was reprobed with
an antibody to actin as a house keeping protein for
comparison. Results from this experiment suggested that
apoptosis derived from the induction of AS-Core gene
expression is associated with the activation of caspase-9.
We examined whether activation of the downstream
effector molecule caspase-3 or -7 occurs in the caspase
cascade. Lysates from control and experimental hepatocytes
expressing AS-Core gene were prepared after 8 days of
ZnCl2 induction. Lysates were subjected to Western blot
analysis using a rabbit polyclonal antibody to caspase-3, and
activation of caspase-3 in response to AS-Core induction
was not observed. Caspase-7 is expressed in liver tissues
and consists of a zymogen form of ¨34–38 kDa, and is
subject to activation by caspase-9 (Deveraux et al., 1998).
Analysis of caspase-7 revealed a significant reduction of the
zymogen form of this executioner phase caspase associated
with AS-Core-derived apoptosis (Fig. 6, panel B). Results
from this set of experiments suggested that AS-Core gene
expression promotes caspase-9 activation, which precedesactivation of caspase-7 as an effector mechanism for
apoptosis of the immortalized hepatocytes.Discussion
Diverse functional activities have been reported for the
HCV core protein (Choi et al., 2001; Lai and Ware, 2000;
McLauchlan, 2000; Ray and Ray, 2001), which include
encapsidation of viral RNA, a regulatory role on cellular and
unrelated viral promoters, interactions with a number of
cellular proteins, a modulatory role in programmed cell
death under certain conditions, involvement in cell growth
promotion and immortalization, induction of hepatocellular
carcinoma (HCC) in transgenic mice, and a possible
immunoregulatory role. Hepatocellular adenoma or carci-
noma has also been noted in transgenic animals encoding a
complete HCV protein sequence (Lerat et al., 2002). These
intriguing properties suggest that the core protein, in concert
with cellular factors, may contribute to the pathogenesis of a
chronic HCV infection. In general, development of patho-
logical consequences in the host would vary depending
upon the nature of disease, the infecting virus, and the
incubation time. Multiple genetic factors, including host
innate and acquired immune responses, exert distinct
characteristics imposed upon the invading organism. HCV
Fig. 6. Effect of AS-Core gene expression on downstream effector
molecules in IHH. (Panel A) Inhibition of core protein expression in the
IHH activates procaspase-9. Cell lysates were prepared after induction of
AS-Core gene expression or empty vector control and analyzed for
procaspase-9 level by Western blot using a specific antibody. Inhibition
of caspase-9 was observed following treatment of cells with sip53, siE2F1,
or siApaf-1. (Panel B) Inhibition of core protein expression in the IHH
significantly decreases procaspase-7 level. Cell lysates were subjected to
Western blot analysis using antibody to procaspase-7. The level of cellular
actin was used as an internal control for comparison. Molecular weights of
the identified protein bands were validated from the positions of prestained
molecular weight markers (Bio-Rad).
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natural host for virus tropism and replication (Ray et al.,
2000). In infected liver, HCV core protein may stimulate
cells to escape from replicative senescence, allowing for the
rise of selective clonal proliferation. Here, we have shown
that the inhibition of HCV core protein expression in these
immortalized human hepatocytes results in an increase in
p53 and E2F1 expression levels preceding the onset of
apoptosis. HCV core protein also appeared to modulate anti-
apoptotic Bcl-2-related proteins for the maintenance of
hepatocarcinoma by antagonizing proapoptotic molecules.
Apoptosis derived from the inhibition of HCV core protein
expression by antisense sequences correlated with an
upregulation of Apaf-1 and the activation of a caspase-9-
related cascade in the absence of cytosolic accumulation of
cytochrome c.
Apaf-1 constitutes the central element in the intrinsic
pathway, which may be triggered by the release of
cytochrome c from the mitochondrion (Liu et al., 1996).
This translocation of cytochrome c follows a change in
mitochondrial membrane potential likely to be associatedwith the activity of proapoptotic members of the Bcl-2
family. The lack of cytochrome c release in AS-Core-
induced IHH is in contrast to the modulation of Bcl-xL and
Bax proteins apparent in cells that undergo an apoptotic
response related to this induction. Initiation of caspase-9-
associated cell death by inhibition of HCV core protein
expression appears to be the key mechanism of IHH cell
death. The modulation of the intrinsic pathway by this
means may be critical for the maintenance of the
immortalized phenotype of HCV core-transfected human
hepatocytes.
Apaf-1 forms a central element in the mitochondrial
death machinery and is responsible for the recruitment and
activation of initiator caspase-9 by enforcing a locally high
concentration of caspase-9 (Lauber et al., 2001). The close
proximity of the caspase precursors then allows the
immature proteases to self-activate due to their low intrinsic
enzymatic activity (Salvesen and Dixit, 1999). Caspase-9 in
turn activates executioner caspase-3 or caspase-7, thus
perpetuating the caspase cascade which results in cell death
(Slee et al., 1999). Recent studies demonstrated that Apaf-1
might act as an allosteric activator for caspase-9 (Rodriguez
and Lazebnik, 1999; Stennicke et al., 1999). Further,
caspase-9 remains associated with Apaf-1 in a high
molecular weight complex of ¨700 kDa, termed as
apoptosome, that might also contain executioner caspase-3
and -7 (Cain et al., 1999; Hu et al., 1999). After activation of
the downstream caspase pathway, Apaf-1 itself is processed
into an proteolytic 84-kDa fragment as a target of caspase
proteolytic activity, forming an inactive multimer, which is
unable to further bind the caspase recruitment domain
(CARD) (Lauber et al., 2001).
E2F-1 enhances the expression of Apaf-1 leading to cell
death without the cytosolic accumulation of cytochrome c.
Resistance of Apaf-1-deficient melanoma cell lines to the
deregulated expression of E2F-1 suggests that Apaf-1 is an
essential element of E2F-1-mediated apoptosis (Furukawa et
al., 2002). E2F-1 activates caspase-9 by directly inducing
the autoactivation of caspase-9 via a localized increase in
intracellular Apaf-1 levels. In this manner, the cell may
initiate a caspase cascade in the absence of mitochondrial
damage. In our study, we observed a significant increase of
Apaf-1 in cells undergoing apoptosis associated with AS-
Core gene expression. Fortin et al. (2001) reported that p53
up-regulates Apaf-1 as a direct transcriptional target during
neuronal cell death. E2F-1 may also transactivate the Apaf-1
gene in the absence of p53 (Furukawa et al., 2002). This
may have clinical importance, as the loss of normal p53
function is a common characteristic of a number of cancer
cell types. The E2F-1/Apaf-1 pathway (growth-associated
intrinsic route) works in parallel with the p53/Bax/cyto-
chrome c pathway (DNA damage-triggered extrinsic route)
in promoting apoptotic cell death. The loss of p53 pathway
function and deregulated E2F activity infers the possibility
that E2F1 may induce apoptosis directly or independently of
p53 induction. Apaf-1 and procaspase-9 have a role in
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these proteins are strong candidates as tumor suppressors
(Moroni et al., 2001). As both E2F1 and p53 transcription-
ally activate Apaf-1, these proteins may sensitize cells to
apoptosis by a process that would circumnavigate the need
for cytochrome c release to initiate the Apaf-1/caspase-9-
associated cell death pathway. Further studies will continue
to study the underlying biochemical changes apparent in
immortalized hepatocytes and how these changes may
reflect those apparent in HCV-infected patients.Table 1
Primers used for amplification of cellular genes
Gene product Primers Sequence (5V–3V)
p53 Forward TGCTTTCCACGACGGTGAC
Reverse AGTGACCCGGAAGGCAGTC
E2F1 Forward GGTTATGGTGATCAAAGCCCC
Reverse CCTGAGACCCAGCTCCAAGCCG
GAPDH Forward TGAAGGTCGGAGTCAACGG
Reverse AGAGTTAAAAGCAGCCCTGGTGMaterials and methods
Cells and plasmids
Primary human hepatocytes immortalized by transfection
with plasmid DNA expressing core protein from HCV
genotype 1a under the control of MuLV LTR in the pBabe-
puro expression vector were generated as described earlier
(Ray et al., 2000). Hepatocytes were seeded on collagen
type I-coated plates and maintained at 37 -C in a defined
culture medium supplemented with growth factors and
antimicrobials (SAGM, Clonetics, CA). The antisense
orientation of the core genomic sequence (encoding amino
acids 1–191) from the same HCV genotype 1a was cloned
under the control of an inducible metallothionein promoter
in MTCB6 + vector (kindly provided by Frank J. Rauscher,
III, Wistar Institute, Philadelphia).
Transfection and maintenance of hepatocytes
HCV core-mediated immortalized hepatocytes (from
passage 15) were transfected with the antisense orientation
of the core genomic region (AS-Core) or an empty vector
using lipofectamine. Briefly, cells were transfected with an
inducible promoter linked with the AS-Core gene or empty
vector DNA (mock control). At 48 h post-transfection, cells
were treated with G-418 (800 Ag/ml) for the selection of
stable transfectants. Isolated colonies were pooled to limit
the potential for clonal artifacts. For induction of AS-Core
gene expression, cells were treated with a predetermined
dose of ZnCl2 (50 AM) for 6–8 days. The addition of ZnCl2
displayed no detectable growth inhibition in the absence of
AS-Core gene sequences.
Immunofluorescence for cytochrome c
IHHs were treated with ZnCl2 (50 AM) to induce AS-
Core gene expression. Upon visual observation of cellular
changes associated with apoptosis, cells were treated with
mitotracker for 30 min, washed, and fixed with 3.7%
formaldehyde in PBS for 30 min. Fixed cells were
permeabilized with 0.2% Triton X-100 in PBS for 5 min.
After washing, cells were incubated with a mouse mono-
clonal antibody to cytochrome c (Promega), followed bystaining with an anti-mouse secondary antibody conjugated
with Alexa-568 (Molecular Probes). Finally, washed cells
were mounted for confocal microscopy (Bio-Rad 1024).
Preparation of cytoplasmic fraction
IHH cells stably transfected with the MTCB6+ vector
with or without the AS-Core gene were treated with ZnCl2
for 8 days. Experimental cells were harvested after death,
resuspended in ice-cold isotonic buffer (20 mM HEPES, pH
7.5, 10 mM KCl, 1.5 mM MgCl 2, 1 mM EDTA, 1 mM
EGTA, 1 mM DTT, 250 mM sucrose, and containing 5 Ag/
ml aprotinin, 2.5 Ag/ml leupeptin, and 3 Ag/ml pepstatin as a
cocktail of protease inhibitor), and fractionated as described
earlier (Bossy-Wetzel et al., 1998). The pellet obtained
comprised the mitochondrial membrane fraction, and the
supernatant contained the cytosolic fraction. Equal amounts
of cytosolic protein extracts and membrane fractions were
resolved by SDS–PAGE (15%) and electroblotted onto a
nitrocellulose membrane. Cytochrome c was detected by
Western blot analysis with a specific antibody to cyto-
chrome c (Santa Cruz), followed by chemiluminescence
(Amersham).
Real-time PCR
Total RNAwas treated with DNase I, reverse transcribed
using random priming and Superscript II reverse tran-
scriptase following manufacturer’s procedure (Invitrogen).
Quantitative PCR was performed by monitoring in real-time
the increase in fluorescence of the SYBR Green dye on an
ABI PRISM 7000 Sequence Detector System (Applied
Biosystems) according to the manufacturer’s protocol.
Gene-specific primers (Invitrogen) were designed using
the Primer Express software from Applied Biosystems
(Table 1). Relative expression levels of the target genes in
immortalized hepatocytes were plotted as fold change
compared with a matched untransfected primary control;
18 S rRNA was used for normalization. Each real-time
quantitative PCR assay was performed twice using triplicate
samples.
Gene array
RNA isolation from cells and generation of 32P-labeled
cDNA probes were performed as recommended by the
K. Meyer et al. / Virology 336 (2005) 198–207206supplier for gene array (CLONTECH Laboratories, Inc.,).
In brief, total RNA was isolated from frozen cell pellets
and DNase treated. mRNA was isolated from total RNA
using oligo(dT)-conjugated magnetic beads. Radiolabeled
cDNA probes were generated by reverse transcription of
0.5–1 Ag of mRNA (the same amount for stimulated and
control in each case) using Moloney murine leukemia
virus polymerase in the presence of [O-32P]dATP. Hybrid-
ization of the cDNA probes to Atlas membranes (Human
Oncogene/Tumor Suppressor Array) was done overnight at
68 -C in ExpressHyb (CLONTECH) using mRNA isolated
from independent experiments on two different filter sets.
The results were analyzed using a PhosphorImager
(Molecular Dynamics). Differential expression was deter-
mined as the percent deviation from control after normal-
izing all spots according to the average relative intensities
of the nine housekeeping genes on stimulated and control
membranes. cDNA spots that showed substantial deviation
from control membranes were selected. The threshold was
set around 60–100% for up-regulation and 40–60% for
down-regulation.
Small interfering RNA (siRNA)
The 21-nucleotide siRNA duplexes targeted to p53,
E2F1, and Apaf-1 were purchased from Santa Cruz, CA.
The relevant siRNAs (100 nM) were introduced into IHH by
electroporation (Bio-Rad), and cells were treated with ZnCl2
for induction of AS-Core expression. Cells were collected
after induction for subsequent studies.
RNAse protection assay
An RNAse protection assay was performed using custom
made probes (Pharmingen) to investigate the modulation of
cellular genes as previously described (Basu et al., 2001).
Control human RNA provided with the assay kit was used
to ensure the detection of specific bands. Total cellular RNA
was isolated from vector-transfected control or AS-Core-
transfected cells. Total RNA was hybridized with radio-
labeled antisense RNA multiprobes (Bcl-xL, Bax, Bcl2, and
L32). The reaction mixture was digested with RNAse A and
RNAse T1. The protected fragments were analyzed by urea-
polyacrylamide gel (5%) electrophoresis, followed by auto-
radiography. The autoradiogram was densitometrically
scanned to compare mRNA levels between control and
experimental cells after normalizing the values with respect
to the housekeeping gene, L32.
Western blot
IHHs expressing the AS-core sequences or vector alone
were treated in parallel with ZnCl2 (50 AM) for 8 days until
apoptotic induction in the experimental set was apparent.
Cells were washed in phosphate-buffered saline and lysed in
0.5% SDS, 125 mM Tris–HCl, pH 6.8, and 10% 2-mercaptoethanol containing 5 Ag/ml aprotinin, 2.5 Ag/ml
leupeptin, and 3 Ag/ml pepstatin. Proteins were resolved by
SDS–PAGE and electroeluted to a nitrocellulose mem-
brane. The membrane was blocked for 2 h with 5% nonfat
dry milk in TBS-tween and incubated with appropriate
antibodies. Detection of protein was completed by the
addition of an enhanced chemiluminescent substrate,
according to the manufacturer’s protocol (Amersham).
Antibodies
Rabbit antibody to Bax, procaspase-9, and procaspase-7,
monoclonal antibodies to p53, and Bcl-xL (Santa Cruz,
CA), monoclonal antibody to Apaf-1 (R D System, MN),
and monoclonal antibodies to actin, Bcl2, and E2F1
(Oncogene Science, CA) were purchased from the respec-
tive manufacturer.
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